Oppenheimer Asset Management Inc. Makes New $1.43 Million Investment in HCA Healthcare, Inc. $HCA

Oppenheimer Asset Management Inc. purchased a new position in HCA Healthcare, Inc. (NYSE:HCA) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,669 shares of the company’s stock, valued at approximately $1,431,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Nomura Asset Management Co. Ltd. raised its position in shares of HCA Healthcare by 6.2% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock valued at $29,990,000 after buying an additional 3,724 shares in the last quarter. Advisors Capital Management LLC increased its stake in HCA Healthcare by 61.5% in the fourth quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock valued at $3,192,000 after acquiring an additional 2,604 shares during the last quarter. Liberty Wealth Management LLC purchased a new position in shares of HCA Healthcare in the 4th quarter worth about $1,905,000. Arrowstreet Capital Limited Partnership raised its holdings in shares of HCA Healthcare by 11.9% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock valued at $1,078,966,000 after buying an additional 245,887 shares in the last quarter. Finally, Sunbelt Securities Inc. grew its position in HCA Healthcare by 171.7% during the first quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock valued at $2,954,000 after acquiring an additional 3,945 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Down 0.0%

NYSE HCA opened at $404.61 on Monday. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52. The firm has a market capitalization of $87.60 billion, a PE ratio of 13.55, a P/E/G ratio of 1.40 and a beta of 1.10. The stock’s 50 day moving average is $393.41 and its 200 day moving average is $446.61.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The company had revenue of $20.23 billion during the quarter, compared to analysts’ expectations of $19.76 billion. During the same period last year, the company posted $6.84 EPS. HCA Healthcare’s revenue was up 8.7% on a year-over-year basis. On average, research analysts anticipate that HCA Healthcare, Inc. will post 29.47 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be issued a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s payout ratio is 10.45%.

Analyst Upgrades and Downgrades

HCA has been the topic of several recent research reports. Barclays reduced their target price on shares of HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating on the stock in a report on Monday, July 27th. Leerink Partners lowered their target price on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a research note on Monday, April 27th. Mizuho decreased their price target on HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 28th. Jefferies Financial Group set a $450.00 target price on shares of HCA Healthcare in a report on Tuesday, July 14th. Finally, Deutsche Bank Aktiengesellschaft set a $476.00 price objective on shares of HCA Healthcare in a research report on Monday, July 27th. Fourteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and a consensus target price of $465.59.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.